midazolam has been researched along with Jaw Cysts in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Jaw Cysts: Saccular lesions lined with epithelium and contained within pathologically formed cavities in the jaw; also nonepithelial cysts (pseudocysts) as they apply to the jaw, e.g., traumatic or solitary cyst, static bone cavity, and aneurysmal bone cyst. True jaw cysts are classified as odontogenic or nonodontogenic.
Excerpt | Relevance | Reference |
---|---|---|
"Midazolam and Propofol were used following a bolus-infusion sequence, both separately and in combination among themselves (MID\\PROP group), or with an opioid, Remifentanil (MID\\PROP\\REMI group)." | 2.72 | Neurosedation in dentistry of the disabled patient: the use of midazolam, propofol, and remifentanil. ( Barraco, G; Collini, S; Di Carlo, S; Gatto, R; Lejeune, L; Meloncelli, S; Pinto, G, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collini, S | 1 |
Pinto, G | 1 |
Lejeune, L | 1 |
Di Carlo, S | 1 |
Meloncelli, S | 1 |
Barraco, G | 1 |
Gatto, R | 1 |
1 trial available for midazolam and Jaw Cysts
Article | Year |
---|---|
Neurosedation in dentistry of the disabled patient: the use of midazolam, propofol, and remifentanil.
Topics: Adult; Conscious Sedation; Dental Anxiety; Dental Implantation; Disabled Persons; Drug Synergism; Dr | 2006 |